Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab
-
* Corresponding authors: Christophe Richez christophe.richez@mac.com - Patrick Blanco patrick.blanco@chu-bordeaux.fr
Arthritis Research & Therapy 2009, 11:R100 doi:10.1186/ar2746
No comments have yet been made on this article.